Page last updated: 2024-11-07

tolmetin glycinamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID135911
SCHEMBL ID3051890
MeSH IDM0162151

Synonyms (19)

Synonym
mcn-4366
unii-3rs348sv6u
glycine, n-((1-methyl-5-(4-methylbenzoyl)-1h-pyrrol-2-yl)acetyl)-
tolmetin glycine amide
3rs348sv6u ,
tolmetin glycineamide
tolmetin glycinamide
2-[[2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetyl]amino]acetic acid
87344-05-6
AKOS015901744
glycine, n-(2-(1-methyl-5-(4-methylbenzoyl)-1h-pyrrol-2-yl)acetyl)-
n-((1-methyl-5-p-toluoylpyrrol-2-yl)acetyl)glycine
mcn 4366
amtolmetin
SCHEMBL3051890
DTXSID90236290
(s)-3-acetoxy-4-bromobutyrylchloride
Q27257950
{2-[1-methyl-5-(4-methyl-benzoyl)-1h-pyrrol-2-yl]-acetylamino}-acetic acid

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"It may be concluded that BCRP plays an important role in the intestinal efflux of MED-5 and limits the bioavailability after oral administration of MED-15."( Evaluation of intestinal absorption of amtolmetin guacyl in rats: breast cancer resistant protein as a primary barrier of oral bioavailability.
Li, X; Liu, D; Rong, Z; Xiang, D; Xu, Y; Zhang, C, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's3 (60.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.59 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (40.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other3 (60.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]